ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE

ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE

Show other versions (1)

Evidence based medicine data on ability of antiplatelet, including dual antiplatelet, therapy to improve the life expectancy of patients with high risk of thrombotic complications, especially patients with acute myocardial infarction is presented in brief. The problem of choosing a drug and resistan...

Full description

Bibliographic Details
Main Authors:	S. Yu. Martsevich, N. P. Kutishenko, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Klinicist
Subjects:	antiplatelet agents aspirin clopidogrel myocardial infarction drug resistance proton pump inhibitors
Online Access:	https://klinitsist.abvpress.ru/Klin/article/view/125

Similar Items

ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
by: S. Yu. Martsevich, et al.
Published: (2014-07-01)

UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy
by: Masashi Kubota, et al.
Published: (2024-03-01)

Antiplatelet treatment patterns and outcomes of secondary stroke prevention in the United States
by: Ellen O'Brien, et al.
Published: (2023-02-01)

Non-responsiveness to oral antiplatelet treatment
by: Rok Perme, et al.
Published: (2006-10-01)

Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events
by: Leonardo De Luca, et al.
Published: (2021-04-01)

Antiplatelet resistance and thromboembolic complications in neurointerventional procedures
by: Thomas J Oxley, et al.
Published: (2011-12-01)

Use of Antiplatelet Agents Decreases the Positive Predictive Value of Fecal Immunochemical Tests for Colorectal Cancer but Does Not Affect Their Sensitivity
by: Yoonsuk Jung, et al.
Published: (2021-06-01)

Real-world experience of clinical management with antiplatelet and lipid-lowering therapy in post acute coronary syndrome patients in Indian setting
by: M S Hiremath, et al.
Published: (2021-01-01)

MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: N. F. Puchinian, et al.
Published: (2017-03-01)

Antiplatelet Therapy in Atherothrombotic Diseases: Similarities and Differences Across Guidelines
by: Georges Jourdi, et al.
Published: (2022-04-01)

Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction
by: Yong Kang Lee, et al.
Published: (2023-08-01)

Clopidogrel Resistance in Patients With Stroke Recurrence Under Single or Dual Antiplatelet Treatment
by: Hyun Goo Kang, et al.
Published: (2021-08-01)

THE MODERN ASPECTS OF CLOPIDOGREL USE
by: E. N. Dankovtseva, et al.
Published: (2016-01-01)

Evaluation of bleeding following dental extraction in patients on long-term antiplatelet therapy: A clinical trial
by: K George Varghese, et al.
Published: (2015-01-01)

The Effects of Dual Antiplatelet Therapy on the Occurrence of Recurrent Cardiovascular Events After Myocardial Infarction in Obese Patients
by: Borovyk K., et al.
Published: (2019-04-01)

Efficacy and safety of antiplatelet drugs in patients with chronic kidney disease
by: İbrahim Yıldız, et al.
Published: (2014-07-01)

THE EFFECTIVENESS OF CLOPIDOGREL AS AN ANTITHROMBOTIC COMPARED TO TICLOPIDINE AND ASPIRIN (META-ANALYSIS)
by: Titien Siwi Hartayu, et al.
Published: (2017-05-01)

Comparison of the Degree of Gastric Mucosal Injury between Patients Who Are Receiving Dual Antiplatelet Therapy or Single Antiplatelet Therapy
by: Yuji Shimada, et al.
Published: (2022-09-01)

Dual antiplatelet therapy is associated with high α-tubulin acetylation in circulating platelets from coronary artery disease patients
by: Valentine Robaux, et al.
Published: (2023-12-01)

Dual Antiplatelet Therapy Regimens and Duration for Intracranial Stenting Procedures: Literature Review
by: Milda Paliulytė, et al.
Published: (2023-11-01)

Single and dual antiplatelet therapy in elderly patients of medically managed myocardial infarction
by: Ting-Tse Lin, et al.
Published: (2018-04-01)

Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials
by: Mahmoud Barbarawi, et al.
Published: (2019-01-01)

Duration of Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement: Systematic Review and Network Meta‐Analysis
by: Toshiki Kuno, et al.
Published: (2021-05-01)

Antiplatelet combinations for prevention of atherothrombotic events
by: Anselmino M, et al.
Published: (2011-01-01)

Triple Antiplatelet Therapy with Cilostazol and Favorable Early Clinical Outcomes after Acute Myocardial Infarction Compared to Dual Antiplatelet Therapy with Standard or Potent P2Y12 Inhibitors
by: Sungwook Byun, et al.
Published: (2022-11-01)

Antiplatelet drugs and gastrointestinal disorders: when and how effective are inhibitors of proton pump?
by: Oksana Mikhaylovna Drapkina, et al.
Published: (2011-10-01)

Incidence of major adverse cardiovascular events with genotype test guided antiplatelet treatment strategy after percutaneous coronary intervention
by: S. Ramesh, et al.
Published: (2020-11-01)

Prevention of Peptic Ulcer Associated with Aspirin and Antiplatelet Agent
by: Ji Yong Ahn
Published: (2020-11-01)

Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis
by: Xiaofeng Luo, et al.
Published: (2023-01-01)

DENTAL MANAGEMENT AND BLEEDING COMPLICATIONS OF PATIENTS ON LONG-TERM ORAL ANTIPLATELET THERAPY. REVIEW OF EXISTING STUDIES AND GUIDELINES.
by: Atanaska Dinkova, et al.
Published: (2013-06-01)

Antiplatelet Therapy Aims and Strategies in Asian Patients with Acute Coronary Syndrome or Stable Coronary Artery Disease
by: Chor-Cheung Tam, et al.
Published: (2022-12-01)

СONCOMITANT ADMINISTRATION OF CLOPIDOGREL AND PROTON PUMP INHIBITORS: ARE THERE ANY OPEN QUESTIONS LEFT TODAY?
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

Percutaneous native kidney biopsy in patients receiving antiplatelet agents- is it necessary to stop them routinely?
by: S Nayak-Rao
Published: (2015-01-01)

Clopidogrel in the treatment of patients with ST-elevation acute myocardial infarction: state-of-art in 2013
by: O. V. Averkov
Published: (2013-02-01)

Atraumatic Splenic Rupture after Myocardial Infarction
by: Muhammad Fahad Arshad, et al.
Published: (2018-02-01)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
by: Jianyu Qu, et al.
Published: (2021-06-01)

Dual Antiplatelet Therapy for the Acute Management and Long-term Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack, An Updated Review
by: Bernard P. L. Chan, et al.
Published: (2024-01-01)

Risk of bleeding in patients undergoing percutaneous endoscopic gastrotrostomy (PEG) tube insertion under antiplatelet therapy: a systematic review with a meta-analysis
by: Alfredo J. Lucendo, et al.
Published: (2015-03-01)